成功治疗慢性丙型肝炎无应答患者的隐匿性乙型肝炎活动期。
Successful treatment of activated occult hepatitis B in a non-responder chronic hepatitis C patient.
机构信息
Tropical Medicine Department, Faculty of Medicine, Zagazig University, Egypt.
出版信息
Virol J. 2011 Nov 14;8:518. doi: 10.1186/1743-422X-8-518.
Abstract
We reported a 23 years old male with chronic hepatitis C virus infection, discontinued from pegylated interferon/ribavirin combination therapy due to a lack of early virological response. He has developed activation of occult hepatitis B virus that was successfully treated by a one year of lamivudine therapy.
摘要
我们报道了一例 23 岁男性慢性丙型肝炎病毒感染者，因早期病毒学应答不佳而停止聚乙二醇干扰素/利巴韦林联合治疗。他出现了隐匿性乙型肝炎病毒的激活，经一年拉米夫定治疗后成功治愈。
相似文献
1
Successful treatment of activated occult hepatitis B in a non-responder chronic hepatitis C patient.
Virol J. 2011 Nov 14;8:518. doi: 10.1186/1743-422X-8-518.
2
[Antiviral therapy in children with chronic hepatitis B and children with chronic hepatitis C].
Zhonghua Er Ke Za Zhi. 2014 Aug;52(8):563-6.
3
Impact of occult hepatitis B virus infection or hepatitis B virus DNA integration on efficacy of chronic hepatitis C treatment with peginterferon and ribavirin: where are we?
J Clin Gastroenterol. 2014 Jan;48(1):3-5. doi: 10.1097/MCG.0b013e3182a6633d.
4
Pegylated interferon (alone or with ribavirin) for chronic hepatitis C in haemodialysis population.
Kidney Blood Press Res. 2015;40(3):258-65. doi: 10.1159/000368501. Epub 2015 May 14.
5
A European single centre experience of management of hepatitis C virus genotype 4 infection with pegylated-interferon and ribavirin.
J Med Virol. 2015 Oct;87(10):1716-21. doi: 10.1002/jmv.24228. Epub 2015 Apr 24.
6
[Experiences in antiviral treatment of chronic viral hepatitis B and C in Hungary (1998-2004)].
Orv Hetil. 2007 May 6;148(18):819-26. doi: 10.1556/OH.2007.28114.
7
Peginterferon-α2a combined with response-guided short-term lamivudine improves response rate in hepatitis B e antigen-positive hepatitis B patients: a pilot study.
Eur J Gastroenterol Hepatol. 2013 Oct;25(10):1165-9. doi: 10.1097/MEG.0b013e3283612e95.
8
[Antiviral therapy for chronic viral hepatitis B and C].
Nihon Rinsho. 2003 Feb;61 Suppl 2:787-91.
9
Sustained virologic response and IL28B single-nucleotide polymorphisms in patients with chronic hepatitis C treated with pegylated interferon alfa and ribavirin.
Acta Biochim Pol. 2012;59(3):333-7. Epub 2012 Aug 27.
10
[Interferon therapy for chronic hepatitis B].
Zhonghua Gan Zang Bing Za Zhi. 2009 Oct;17(10):726-9.
本文引用的文献
1
Occult hepatitis B infection in egyptian chronic hepatitis C patients: prevalence, impact on pegylated interferon/ribavirin therapy.
Virol J. 2010 Nov 17;7:324. doi: 10.1186/1743-422X-7-324.
2
EASL Clinical Practice Guidelines: management of chronic hepatitis B.
J Hepatol. 2009 Feb;50(2):227-42. doi: 10.1016/j.jhep.2008.10.001. Epub 2008 Oct 29.
3
Statements from the Taormina expert meeting on occult hepatitis B virus infection.
J Hepatol. 2008 Oct;49(4):652-7. doi: 10.1016/j.jhep.2008.07.014. Epub 2008 Jul 31.
4
Liver enzyme flares and occult hepatitis B in persons with chronic hepatitis C infection.
J Clin Virol. 2007 Jun;39(2):101-5. doi: 10.1016/j.jcv.2007.03.006. Epub 2007 Apr 23.
5
Diagnostic impact of the genetic variability of the hepatitis B virus surface antigen gene.
J Med Virol. 2006;78 Suppl 1:S59-65. doi: 10.1002/jmv.20610.
6
Occult HBV infection and suppression of HCV replication in the early phase of combination therapy for chronic hepatitis C.
J Biol Regul Homeost Agents. 2003 Apr-Jun;17(2):172-5.
7
Persistent hepatitis B virus infection in subjects without hepatitis B surface antigen: clinically significant or purely "occult"?
Hepatology. 2001 Jul;34(1):194-203. doi: 10.1053/jhep.2001.25172.
8
Co-infection by serologically-silent hepatitis B virus may contribute to poor interferon response in patients with chronic hepatitis C by down-regulation of type-I interferon receptor gene expression in the liver.
J Med Virol. 2001 Mar;63(3):220-7. doi: 10.1002/1096-9071(200103)63:3<220::aid-jmv1004>3.0.co;2-3.
9
The clinical features of chronic hepatitis C are not affected by the coexistence of hepatitis B virus DNA in patients negative for hepatitis B surface antigen.
Intervirology. 2000;43(2):95-101. doi: 10.1159/000025030.
10
Occult hepatitis B virus infection in patients with chronic hepatitis C liver disease.
N Engl J Med. 1999 Jul 1;341(1):22-6. doi: 10.1056/NEJM199907013410104.
Zotero 插件